Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-16 Sale | 2024-08-20 4:26 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 9,650 | $18.5 | $178,564 | 1,124,657 (Indirect Direct) | View |
| 2024-05-16 Sale | 2024-05-20 4:33 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 9,790 | $23.35 | $228,597 | 1,317,757 (Indirect Direct) | View |
| 2024-02-16 Sale | 2024-02-21 8:54 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 20,272 | $29.84 | $604,876 | 1,223,913 (Indirect Direct) | View |
| 2023-08-17 Sale | 2023-08-21 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 4,767 | $15.47 | $73,750 | 931,092 (Indirect Direct) | View |
| 2023-05-17 Sale | 2023-05-19 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 4,122 | $21.38 | $88,108 | 927,880 (Indirect Direct) | View |
| 2023-02-17 Sale | 2023-02-22 7:27 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 12,194 | $19.06 | $232,418 | 536,885 (Direct) | View |
| 2022-02-07 Purchase | 2022-02-08 4:43 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 22,000 | $17.34 | $381,513 | 923,877 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-02-14 Other | 2024-05-20 4:33 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 91,725 | $0 | 1,317,757 (Direct) | View |
| 2024-05-14 Exercise | 2024-05-20 4:33 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 17,662 | $0 | 1,317,757 (Direct) | View |
| 2024-02-16 Option Award | 2024-02-21 8:54 pm | N/A 2034-02-16 | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 262,913 | $0 | 1,223,913 (Direct) | View |
| 2024-02-14 Exercise | 2024-02-16 4:05 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 93,656 | $0 | 1,090,659 (Direct) | View |
| 2023-11-14 Exercise | 2023-11-16 7:09 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 7,979 | $0 | 978,969 (Direct) | View |
| 2023-08-14 Exercise | 2023-08-15 4:06 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 7,979 | $0 | 983,736 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-14 7:01 pm | N/A 2033-06-13 | Talaris Therapeutics Inc. | TALS | Shah Gaurav Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2023-05-14 Exercise | 2023-05-16 8:04 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 7,979 | $0 | 987,858 (Direct) | View |
| 2023-02-14 Option Award(A) | 2023-02-22 7:25 pm | N/A 2033-02-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 464,907 | $0 | 1,484,059 (Direct) | View |
| 2023-02-14 Exercise(A) | 2023-02-22 7:25 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 31,440 | $0 | 1,484,059 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-16 4:45 pm | N/A 2033-02-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 464,907 | $0 | 464,907 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 6:16 pm | N/A 2032-06-08 | Talaris Therapeutics Inc. | TALS | Shah Gaurav Director | 14,501 | $0 | 14,501 (Direct) | View |
| 2022-02-14 Option Award | 2022-02-16 9:02 pm | N/A 2032-02-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 392,312 | $0 | 392,312 (Direct) | View |
Ownership | 2021-05-06 9:18 pm | N/A 2030-12-04 | Talaris Therapeutics Inc. | TALS | Shah Gaurav Director | 0 | $0 | 76,635 (Direct) | View |
| 2021-04-01 Tax Withholding | 2021-04-01 9:09 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 7,475 | $47.21 | 901,877 (Direct) | View |
| 2021-03-31 Tax Withholding | 2021-04-01 9:09 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 7,493 | $45.94 | 901,877 (Direct) | View |
| 2021-04-01 Tax Withholding | 2021-04-01 9:09 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 5,919 | $45.21 | 901,877 (Direct) | View |
| 2021-04-01 Tax Withholding | 2021-04-01 9:09 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 8,872 | $46.45 | 901,877 (Direct) | View |
| 2021-03-30 Tax Withholding | 2021-04-01 9:08 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 8,667 | $42.8 | 931,636 (Direct) | View |
| 2021-03-30 Tax Withholding | 2021-04-01 9:08 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 19,984 | $41.8 | 931,636 (Direct) | View |
| 2021-03-31 Exercise | 2021-04-01 9:08 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 75,880 | $1.69 | 931,636 (Direct) | View |
| 2021-03-31 Tax Withholding | 2021-04-01 9:08 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 3,000 | $45.59 | 931,636 (Direct) | View |
| 2021-03-30 Tax Withholding | 2021-04-01 9:08 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 48,732 | $43.86 | 931,636 (Direct) | View |
| 2021-03-30 Tax Withholding | 2021-04-01 9:08 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 8,505 | $44.34 | 931,636 (Direct) | View |
| 2021-03-31 Tax Withholding | 2021-04-01 9:08 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 23,003 | $45.06 | 931,636 (Direct) | View |
| 2021-03-31 Tax Withholding | 2021-04-01 9:08 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 61,350 | $44.24 | 931,636 (Direct) | View |
| 2021-03-31 Exercise | 2021-04-01 9:08 pm | N/A 2027-04-12 | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 75,880 | $0 | 931,636 (Direct) | View |
| 2020-12-09 Ownership | 2021-02-16 9:55 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav President & CEO | 406,238 | $0 | 821,100 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-08 8:41 pm | N/A 2031-02-03 | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav President & CEO | 185,000 | $0 | 185,000 (Direct) | View |
| 2020-03-24 Tax Withholding | 2020-03-26 7:48 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav President & CEO | 32,645 | $13.78 | 1,028,997 (Direct) | View |
| 2020-03-24 Exercise | 2020-03-26 7:48 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav President & CEO | 90,925 | $0.43 | 1,028,997 (Direct) | View |
| 2020-03-24 Exercise | 2020-03-26 7:48 pm | N/A 2020-12-15 | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav President & CEO | 90,925 | $0 | 1,028,997 (Direct) | View |
| 2020-02-25 Tax Withholding | 2020-02-27 5:36 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav President & CEO | 6,233 | $20.15 | 1,061,642 (Direct) | View |
| 2020-02-25 Exercise | 2020-02-27 5:36 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav President & CEO | 290,000 | $0.4332 | 1,061,642 (Direct) | View |
| 2020-02-25 Exercise | 2020-02-27 5:36 pm | N/A 2020-12-15 | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav President & CEO | 290,000 | $0 | 1,061,642 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-10 5:08 pm | N/A 2030-02-06 | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav President & CEO | 383,306 | $0 | 383,306 (Direct) | View |